Protect America’s Innovation and Economic Security from CCP Act of 2025

What happened: HR1468, the 'Protect America’s Innovation and Economic Security from CCP Act of 2025,' was reported out of the House Judiciary Committee on 2026-03-26 with a 14-9 party-line vote. It has not yet received floor action. The bill creates a new 'CCP Initiative' within the DOJ's National Security Division to counter Chinese intellectual property theft, economic espionage, and supply chain risks. It has 13 cosponsors, all Republicans, led by Rep. Gooden (R-TX-5). A companion bill (S672) has been introduced in the Senate but remains at the referral stage.

The money trail: HR1468 authorizes zero direct funding. The bill creates a directive for DOJ to develop enforcement strategies and investigations, but no appropriated dollars or authorized spending ceilings are included. Without appropriations from a separate bill, the program cannot hire staff or deploy resources. This is a policy directive without fiscal teeth.

Structural winners and losers: No near-term sector impact. The bill targets illegal activity (IP theft, economic espionage, FCPA violations) rather than creating procurement, grants, or tax incentives. Cybersecurity companies like $PANW, $CRWD, $FTNT, and $S are structurally positioned to benefit from any future federal enforcement uptick that drives private-sector compliance spending, but HR1468 itself creates no direct revenue stream. No tickers merit inclusion based on causal distance exceeding inferential thresholds.

Market data analysis: $PANW at $178.20 has gained 11.15% over 30 days despite a -0.19% 7-day pullback. $CRWD at $445.82 is up 14.19% over 30 days with a -0.52% weekly decline. Both are trading below their 52-week highs ($223.61 for PANW, $566.90 for CRWD). These moves correlate with broader sector trends and earnings momentum, not legislative catalysts. The bill's progress is irrelevant to current price action.

Timeline: HR1468 requires approval from the House Rules Committee, then a floor vote in the House, then Senate passage (S672 or identical language), and then Presidential action. Given zero funding and a partisan committee vote, passage probability is moderate but impact remains negligible without appropriations. The next legislative window is late 2026 or 2027.